Caption Management’s Axsome Therapeutics AXSM Stock Holding History

Caption Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.1M	Sell	53,500 -8,300	-13%	-$1.8M	0.06%	328
2026 Q1	$10.4M	Buy	61,800 +36,800	+147%	+$6.36M	0.06%	324
2025 Q4	$4.57M	Hold	25,000	–	–	0.03%	549
2025 Q3	$3.04M	Hold	25,000	–	–	0.02%	666
2025 Q2	$2.61M	Hold	25,000	–	–	0.03%	637
2025 Q1	$2.92M	Sell	25,000 -195,000	-89%	-$22.2M	0.03%	565
2024 Q4	$18.6M	Buy	+220,000	New	+$20.2M	0.18%	90
2024 Q2	–	Sell	-32,900	Closed	-$2.63M	–	1151
2024 Q1	$2.63M	Buy	+32,900	New	+$2.76M	0.04%	460
2023 Q3	–	Sell	-27,500	Closed	-$1.98M	–	1266
2023 Q2	$1.98M	Sell	27,500 -2,500	-8%	-$184K	0.04%	497
2023 Q1	$1.85M	Sell	30,000 -5,000	-14%	-$328K	0.04%	460
2022 Q4	$2.7M	Buy	+35,000	New	+$2.09M	0.04%	479
2022 Q3	–	Sell	-20,000	Closed	-$766K	–	1489
2022 Q2	$766K	Sell	20,000 -209,000	-91%	-$6.61M	0.01%	959
2022 Q1	$9.48M	Buy	229,000 +56,000	+32%	+$1.74M	0.11%	226
2021 Q4	$6.54M	Hold	173,000	–	–	0.07%	374
2021 Q3	$5.7M	Buy	+173,000	New	+$6.74M	0.07%	397
2020 Q2	–	Sell	-306,400	Closed	-$18M	–	928
2020 Q1	$18M	Buy	+306,400	New	+$25M	1.02%	6

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caption Management's AXSM Position: Q1 2025 in Review

Caption Management sold out of Axsome Therapeutics (AXSM) in Q1 2025, closing a stake of 115,686 shares — an estimated $13.2M sold.

Caption Management first reported a position in AXSM in Q1 2019 and held it in 10 quarters. The position peaked at $9.79M in Q4 2024. 353 funds tracked by Wall St. Rank hold AXSM as of Q1 2025.

Caption Management reported no remaining Axsome Therapeutics position as of Q1 2025 after selling out during the quarter.
Caption Management sold 115,686 Axsome Therapeutics shares in Q1 2025, an estimated $13.2M.
Caption Management first reported a position in Axsome Therapeutics in Q1 2019 and held it in 10 quarters.
Caption Management's Axsome Therapeutics position peaked at $9.79M in Q4 2024.
353 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.